๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The effect of orgasm on prostate-specific antigen

โœ Scribed by R. F. Kropman; W. Kieviet; R. C. M. Pelger; P. L. Venema


Publisher
Springer-Verlag
Year
1994
Tongue
English
Weight
264 KB
Volume
12
Category
Article
ISSN
0724-4983

No coin nor oath required. For personal study only.

โœฆ Synopsis


S u m m a r y . To identify the effect of orgasm on serum prostate-specific antigen (PSA) levels, a prospective trial before and after orgasm was performed in 14 healthy colleagues aged 3 2 -6 2 years (mean, 44.4 years) with no evidence of prostatic disease. P S A determinations were performed on serum samples obtained before and after orgasm. Significant changes in P S A levels after orgasm were found (P = 0.002, analysis of variance). We conclude that the impact of orgasm on P S A levels should be taken into account when the latter are used for the detection of prostatic disease.


๐Ÿ“œ SIMILAR VOLUMES


Androgen effect on prostate specific ant
โœ Dr. Kamal A. Hanash; Kash F. Mostofi ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 271 KB

## Abstract Prolonged parenteral androgen therapy for 1 year resulted in the hypersecretion of prostate specific antigen (PSA) in a patient with no clinical evidence of prostatic carcinoma, who had been treated with diethylstilbestrol (DES) for 9 years. The PSA level declined to normal values upon

Effect of exogenous testosterone replace
โœ Thomas H. Douglas; Roger R. Connelly; David G. McLeod; Sheila J. Erickson; Rober ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 424 KB

Previous studies have suggested that serum prostate-specific antigen (PSA) levels are under androgenic influence, especially in patients with adenocarcinoma of the prostate. PSMA (prostate-specific membrane antigen) is thought to reflect hormonal or clonal resistance or an independence with respect

Comparison of serum prostate specific me
โœ Thomas H. Douglas; Ted O. Morgan; David G. McLeod; Judd W. Moul; Gerald P. Murph ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 92 KB ๐Ÿ‘ 1 views

ated with higher pathologic stage and grade in patients undergoing radical prostatectomy (RP). In earlier studies, serum prostate specific membrane antigen (PSMA)

The use of prostate specific antigen den
โœ Paul R. Bretton; William P. Evans; James D. Borden; Ronald D. Castellanos ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 442 KB ๐Ÿ‘ 2 views

Background. Prostate specific antigen (PSA) is useful as a tumor marker for monitoring patients with prostate cancer after definitive therapy. Limitations have been noted when PSA was used for the early detection of prostate cancer. The use of prostate specific antigen density [PSAD = PSA (ng/ml)/pr

Prostate-specific antigen in screening o
โœ Dr. T. Ming Chu ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 467 KB ๐Ÿ‘ 1 views

Prostate-specific antigen (PSA) is a wellcharacterized human prostate-specific glycoprotein. PSA has been shown to be the most effective immunohistologic marker for prostate cancer, as well as the most useful serologic test in staging and monitoring prostate cancer and in early detection of recurren